Key result
Editorial highlights novel signaling pathways, endothelial dysfunction, and immune effects of ticagrelor in hypertension.
Why the study?
Hematopoietic cells and their microvesicles have recently emerged as novel markers of cardiovascular risk, and the role of signaling pathways in hypertension remains under investigation.
Design
Editorial summarizing four molecular and translational studies in hypertension and blood
Authors
Loading...
Gavriilaki et al. (2021) conducted an editorial in Cardiovascular diseases and hypertension. This editorial summarizes four articles on molecular advances in hypertension and blood, highlighting novel signaling pathways, immune-modulatory effects of ticagrelor, and endothelial dysfunction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: